TORONTO, Nov. 06, 2026 (GLOBE NEWSWIRE) — Constellation Software Inc. (TSX:CSU) (“Constellation” or the “Company”) today announced its financial results for the third quarter ended September 30, 2026 and declared a $1.00 per share dividend payable on January 12, 2027 to all common shareholders of record at close of business on December 18, 2026. This dividend has been designated as an eligible dividend for the purposes of the Income Tax Act (Canada). Please note that all dollar amounts referred to in this press release are in U.S. Dollars unless otherwise stated.
The following press release should be read in conjunction with the Company’s Unaudited Condensed Consolidated Interim Financial Statements for the three and nine months ended September 30, 2026 and the accompanying notes, our Management Discussion and Analysis for the three and nine months ended September 30, 2026 and with our annual Consolidated Financial Statements, prepared in accordance with International Financial Reporting Standards (“IFRS”) and our annual Management’s Discussion and Analysis for the year ended December 31, 2025, which can be found on SEDAR+ at www.sedarplus.com and on the Company’s website www.csisoftware.com. Additional information about the Company is also available on SEDAR+ at www.sedarplus.com.
Q3 2026 and Subsequent Headlines:
Revenue grew 19% (2% organic growth, 2% after adjusting for changes in foreign exchange rates) to $3,512 million compared to $2,948 million in Q3 2025. Net income attributable to common shareholders was $212 million ($10.01 on a diluted per share basis) compared to $210 million ($9.89 on a diluted per share basis) in Q3 2025.A number of acquisitions were completed for aggregate cash consideration of $484 million (which includes acquired cash). Deferred payments associated with these acquisitions have an estimated value of $125 million resulting in total consideration of $609 million.Cash flows from operations (“CFO”) were $717 million, an increase of 5%, or $33 million, compared to $685 million for the comparable period in 2025.Free cash flow available to shareholders1 (“FCFA2S”) decreased $86 million to $443 million compared to $529 million for the same period in 2025 representing an decrease of 16%.Subsequent to September 30, 2026, the Company completed or has open commitments to acquire a number of businesses for aggregate cash consideration of $526 million on closing plus total estimated deferred payments of $148 million for total consideration of $673 million.
Total revenue for the quarter ended September 30, 2026 was $3,512 million, an increase of 19%, or $564 million, compared to $2,948 million for the comparable period in 2025. For the first nine months of 2026 total revenues were $10,027 million, an increase of 19%, or $1,582 million, compared to $8,446 million for the comparable period in 2025. The increase for both the three and nine month periods compared to the same periods in the prior year is primarily attributable to growth from acquisitions as the Company experienced organic growth of 2% and 4% respectively, 2% and 1% after adjusting for the impact of changes in the valuation of the US dollar against most major currencies in which the Company transacts business. Organic growth is not a standardized financial measure and might not be comparable to measures disclosed by other issuers.
Net income attributable to common shareholders of CSI for the quarter ended September 30, 2026 was $212 million compared to $210 million for the same period in 2025. On a per share basis this translated into a net income per diluted share of $10.01 in the quarter ended September 30, 2026 compared to net income per diluted share of $9.89 for the same period in 2025. For the nine months ended September 30, 2026, net income attributable to common shareholders of CSI was $853 million or $40.26 per diluted share compared to $402 million or $18.96 per diluted share for the same period in 2025.
For the quarter ended September 30, 2026, CFO increased $33 million to $717 million compared to $685 million for the same period in 2025 representing an increase of 5%. For the first nine months of 2026, CFO increased $148 million to $2,092 million compared to $1,944 million during the same period in 2025, representing an increase of 8%.
For the quarter ended September 30, 2026, FCFA2S decreased $86 million to $443 million compared to $529 million for the same period in 2025 representing an decrease of 16%. For the nine months ended September 30, 2026, FCFA2S increased $262 million to $1,522 million compared to $1,259 million for the same period in 2025 representing an increase of 21%. The IRGA / TSS membership liability revaluation charge relating to the investment in equity securities of Sygnity and Asseco was $77 million for the three months ended September 30, 2026 as compared to negative $25 million for the same period in 2025. The charge for the nine months ended September 30, 2026 was negative $36 million as compared to $172 million for the same period in 2025. The fair value of these investments for purposes of calculating the revaluation charge is determined by their respective share prices at the end of each reporting period.
Forward Looking Statements
Certain statements herein may be “forward looking” statements that involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of Constellation or the industry to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Forward looking statements involve significant risks and uncertainties, should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether or not such results will be achieved. A number of factors could cause actual results to vary significantly from the results discussed in the forward looking statements. These forward looking statements reflect current assumptions and expectations regarding future events and operating performance and are made as of the date hereof and Constellation assumes no obligation, except as required by law, to update any forward looking statements to reflect new events or circumstances.
Non-IFRS Measures
Free cash flow available to shareholders ‘‘FCFA2S’’ refers to net cash flows from operating activities less interest paid on lease obligations, interest paid on debt, debt transaction costs, payments of lease obligations, the IRGA / TSS membership liability revaluation charge, and property and equipment purchased, and includes interest and dividends received, and the proceeds from sale of interest rate caps. The portion of this amount applicable to non-controlling interests is then deducted. We believe that FCFA2S is useful supplemental information as it provides an indication of the uncommitted cash flow that is available to shareholders if we do not make any acquisitions, or investments, and do not repay any debts. While we could use the FCFA2S to pay dividends or repurchase shares, our objective is to invest all of our FCFA2S in acquisitions which meet our hurdle rate.
FCFA2S is not a recognized measure under IFRS and, accordingly, readers are cautioned that FCFA2S should not be construed as an alternative to net cash flows from operating activities.
The following table reconciles FCFA2S to net cash flows from operating activities:
Three months ended September 30, Nine months ended September 30, 2026
2025
2026
2025
($ in millions) ($ in millions) Net cash flows from operating activities 717 685 2,092 1,944 Adjusted for: Interest paid on lease obligations (5)(4) (14)(12) Interest paid on debt (66)(59) (170)(153) Debt transaction costs (2)(4) (7)(8) Payments of lease obligations (39)(34) (115)(97) IRGA / TSS membership liability revaluation charge (117)(16) (105)(236) Property and equipment purchased (20)(16) (60)(47) Interest and dividends received 16 13 108 44 484 565 1,729 1,435 Less amount attributable to Non-controlling interests (40)(36) (208)(176) Free cash flow available to shareholders 443 529 1,522 1,259 Due to rounding, certain totals may not foot.
About Constellation Software Inc.
Constellation’s common shares are listed on the Toronto Stock Exchange under the symbol “CSU”. Constellation acquires, manages and builds vertical market software businesses.
For further information:
Jamal Baksh
Chief Financial Officer
(416) 861-9677
info@csisoftware.com
www.csisoftware.com
SOURCE: CONSTELLATION SOFTWARE INC.
CONSTELLATION SOFTWARE INC.
Condensed Consolidated Interim Statements of Financial Position
(In millions of U.S. dollars, except per share amounts. Due to rounding, numbers presented may not foot.) Unaudited September 30, 2026December 31, 2025 Assets Current assets: Cash and cash equivalents$2,693 $3,089 Accounts receivable 1,699 1,466 Unbilled revenue 546 451 Inventories 98 66 Other assets 887 729 5,923 5,800 Non-current assets: Property and equipment 253 240 Right of use assets 396 386 Deferred income taxes 485 355 Investments in associates 637 655 Other assets 497 345 Intangible assets 9,753 8,392 12,021 10,373 Total assets$17,944 $16,173 Liabilities and Shareholders’ Equity Current liabilities: Debt with recourse to Constellation Software Inc.$- $- Liability of CSI under the IRGA 741 775 Debt without recourse to Constellation Software Inc. 433 591 Accounts payable and accrued liabilities 2,064 1,941 Dividends payable 21 21 Deferred revenue 2,543 2,219 Provisions 22 18 Acquisition holdback payables 314 216 Lease obligations 152 143 Income taxes payable 228 150 6,517 6,074 Non-current liabilities: Debt with recourse to Constellation Software Inc. 1,472 1,489 Liability of CSI under the IRGA 554 458 Debt without recourse to Constellation Software Inc. 2,094 2,051 Deferred income taxes 1,048 886 Acquisition holdback payables 277 208 Lease obligations 299 282 Other liabilities 603 457 6,347 5,832 Total liabilities 12,864 11,906 Shareholders’ equity: Capital stock 99 99 Accumulated other comprehensive income (loss) 72 130 Retained earnings 4,136 3,347 Non-controlling interests 772 692 5,080 4,267 Total liabilities and shareholders’ equity$17,944 $16,173
CONSTELLATION SOFTWARE INC.
Condensed Consolidated Interim Statements of Income (loss)
(In millions of U.S. dollars, except per share amounts. Due to rounding, numbers presented may not foot.) Unaudited Three months ended September 30, Nine months ended September 30, 2026
2025
2026
2025
Revenue License$97 $107 $280 $290 Professional services 569 538 1,688 1,558 Hardware and other 131 89 347 244 Maintenance and other recurring 2,715 2,213 7,712 6,354 3,512 2,948 10,027 8,446 Expenses Staff 1,735 1,487 5,118 4,356 Hardware 77 51 200 134 Third party license, maintenance and professional services 361 285 1,004 807 Travel, telecommunications, supplies, software and equipment 192 149 531 424 Professional fees 74 55 207 157 Other, net 77 62 261 205 Depreciation 57 52 167 148 Amortization of intangible assets 376 307 1,049 865 2,948 2,448 8,537 7,095 Foreign exchange loss (gain) (7) (17) (65) 132 IRGA/TSS Membership liability revaluation charge 117 16 105 236 Finance and other expense (income) (4) (83) (64) (191)Share in net (income) loss of equity investees (5) 0 (27) 0 Bargain purchase gain (7) (1) (17) (6)Impairment of intangible and other non-financial assets 6 12 22 23 Revaluation of investment accounted for using the equity method to cost – 260 – 260 Finance costs 84 74 248 216 184 261 200 670 Income (loss) before income taxes 380 239 1,290 681 Current income tax expense (recovery) 194 153 529 445 Deferred income tax expense (recovery) (57) (76) (185) (185)Income tax expense (recovery) 137 77 344 261 Net income (loss) 243 162 946 420 Net income (loss) attributable to: Common shareholders of Constellation Software Inc. 212 210 853 402 Non-controlling interests 31 (48) 93 18 Net income (loss) 243 162 946 420 Earnings per common share of Constellation Software Inc. Basic and diluted$10.01 $9.89 $40.26 $18.96
CONSTELLATION SOFTWARE INC.
Condensed Consolidated Interim Statements of Comprehensive Income (loss)
(In millions of U.S. dollars, except per share amounts. Due to rounding, numbers presented may not foot.)
Unaudited Three months ended September 30, Nine months ended September 30,
2026
2025
2026
2025
Net income (loss)$243 $162 $946 $420 Items that are or may be reclassified subsequently to net income (loss): Foreign currency translation differences from foreign operations and other, net of tax (17) (14) (69) 250 Items that will not be reclassified to net income (loss): Changes in the fair value of equity investments at FVOCI – (5) – 209 Other comprehensive income (loss), net of income tax (17) (19) (69) 459 Total comprehensive income (loss)$226 $142 $877 $879 Total other comprehensive income (loss) attributable to: Common shareholders of Constellation Software Inc. (15) (17) (57) 336 Non-controlling interests (2) (3) (12) 123 Total other comprehensive income (loss)$(17) $(19) $(69) $459 Total comprehensive income (loss) attributable to: Common shareholders of Constellation Software Inc. 197 193 796 738 Non-controlling interests 29 (51) 81 141 Total comprehensive income (loss)$226 $142 $877 $879
CONSTELLATION SOFTWARE INC.
Condensed Consolidated Interim Statement of Changes in Equity
(In millions of U.S. dollars, except per share amounts. Due to rounding, numbers presented may not foot.) Unaudited Nine months ended September 30, 2026 Equity Attributable to Common Shareholders of CSI Capital stock
Accumulated other comprehensive income (loss)Retained earningsTotalNon-controlling interestsTotal equity Balance at January 1, 2026$99 $130 $3,347 $3,576 $692 $4,267 Total comprehensive income (loss): Net income (loss) – – 853 853 93 946 Other comprehensive income (loss) Foreign currency translation differences from foreign operations and other, net of tax and – (57) – (57) (12) (69) Total other comprehensive income (loss) – (57) – (57) (12) (69) Total comprehensive income (loss) – (57) 853 796 81 877 Transactions with owners, recorded directly in equity Other movements in non-controlling interests – – (0) (0) (0) (1) Dividends to shareholders of the Company – – (64) (64) – (64) Balance at September 30, 2026$99 $72 $4,136 $4,307 $772 $5,080
CONSTELLATION SOFTWARE INC.
Condensed Consolidated Interim Statement of Changes in Equity
(In millions of U.S. dollars, except per share amounts. Due to rounding, numbers presented may not foot.) Unaudited Nine months ended September 30, 2025 Equity Attributable to Common Shareholders of CSI Capital stock Accumulated other comprehensive income (loss)Retained earningsTotalNon-controlling interestsTotal equity Balance at January 1, 2025$ 99 $ (224)$ 2,919 $ 2,795 $ 493 $ 3,288 Total comprehensive income (loss): Net income (loss) – – 402 402 18 420 Other comprehensive income (loss) Foreign currency translation differences from foreign operations and other, net of tax and changes in the fair value of equity investments at FVOCI – 336 – 336 123 459 Total other comprehensive income (loss) – 336 – 336 123 459 Total comprehensive income (loss) – 336 402 738 141 879 Transactions with owners, recorded directly in equity Other movements in non-controlling interests – 0 0 0 (1) (0) Dividends paid to non-controlling interests – – – – (0) (0) Dividends to shareholders of the Company – (64) (64) – (64) Balance at September 30, 2025$ 99 $ 112 $ 3,258 $ 3,469 $ 634 $ 4,103
CONSTELLATION SOFTWARE INC.Condensed Consolidated Interim Statements of Cash Flows(In millions of U.S. dollars, except per share amounts. Due to rounding, numbers presented may not foot.) Unaudited Three months ended September 30, Nine months ended September 30, 2026 2025 2026 2025 Cash flows from (used in) operating activities: Net income (loss) 243 162 946 420 Adjustments for: Depreciation 57 52 167 148 Amortization of intangible assets 376 307 1,049 865 IRGA/TSS Membership liability revaluation charge 117 16 105 236 Finance and other expense (income) (4) (83) (64) (191)Share in net (income) loss of equity investees (5) 0 (27) 0 Bargain purchase (gain) (7) (1) (17) (6)Impairment of intangible and other non-financial assets 6 12 22 23 Revaluation of investment accounted for using the equity method to cost – 260 – 260 Finance costs 84 74 248 216 Income tax expense (recovery) 137 77 344 261 Foreign exchange loss (gain) (7) (17) (65) 132 Depreciation of third party costs 4 5 11 14 Change in non-cash operating assets and liabilities exclusive of effects of business combinations (157) (47) (175) (2)Transaction costs associated with equity securities classified as FVOCI – – – (2)Income taxes paid (126) (131) (451) (430)Net cash flows from (used in) operating activities 717 685 2,092 1,944 Cash flows from (used in) financing activities: Interest paid on lease obligations (5) (4) (14) (12)Interest paid on debt (66) (59) (170) (153)Increase (decrease) in Topicus revolving credit debt facility without recourse to CSI 12 301 (251) 197 Proceeds from issuance of debt facilities without recourse to CSI 102 77 700 445 Repayments of debt facilities without recourse to CSI (307) (108) (536) (207)Other financing activities 33 (1) 24 (1)Dividends paid to non-controlling interests – – – (0)Debt transaction costs (2) (4) (7) (8)Payments of lease obligations, net of sublease receipts (39) (34) (115) (97)Dividends paid to common shareholders of the Company (21) (21) (64) (64)Net cash flows from (used in) financing activities (294) 147 (431) 100 Cash flows from (used in) investing activities: Acquisition of businesses (484) (281) (1,913) (755)Cash obtained with acquired businesses 33 44 189 100 Post-acquisition settlement payments, net of receipts (99) (70) (262) (200)Purchases of investments and other assets (25) (36) (72) (225)Proceeds from sales of other investments and other assets 0 0 1 16 Decrease (increase) in restricted cash (28) (289) (26) (284)Interest, dividends and other proceeds received 16 13 108 44 Property and equipment purchased (20) (16) (60) (47)Net cash flows from (used in) investing activities (608) (634) (2,037) (1,351) Effect of foreign currency on cash and cash equivalents (8) (3) (20) 97 Increase (decrease) in cash and cash equivalents (193) 195 (395) 790 Cash and cash equivalents, beginning of period$2,886 $2,575 $3,089 $1,980 Cash and cash equivalents, end of period$2,693 $2,770 $2,693 $2,770
Source: GlobeNewswire